Martin Schwarze, DO, FACC, MACOI – Evolving Lipid Management in the New Decade – Going from the Past to the Future

Course Description

Archive : Martin Schwarze, DO, FACC, MACOI – Evolving Lipid Management in the New Decade – Going from the Past to the Future Digital Download
Salepage : Martin Schwarze, DO, FACC, MACOI – Evolving Lipid Management in the New Decade – Going from the Past to the Future
Delivery : Online With Any Device

This session will teach primary providers concepts, treatments, and new drugs to consider when managing and treating patients with high cholesterol.   It will include new and up to date treatments to help lower, manage, and control cholesterol in patients.  

Learning Objectives:

Review mechanism of action of agents.

Discuss the background of inflammation and its role in diseases.

Highlight guidelines and appropriate drugs to use and when.

The Missouri Association of Osteopathic Physicians and Surgeons is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

The Missouri Association of Osteopathic Physicians and Surgeons is accredited by the American Council for continuing medical education (ACCME) to provide continuing medical education for physicians.

The Missouri Association of Osteopathic Physicians and Surgeons designates this live activity for a maximum of one AMA PRA Category 1 Credit „¢.   Physicians should claim only the credit commensurate with the extent of their participation in the activity.    

Dr. Martin Schwarze is a Clinical Professor of Medicine in the Division of Cardiology of St. Louis University Hospitals and the past Chief of Cardiology at Des Peres Hospital in St. Louis, Mo. He is currently a physician with the Barnes-Jewish Christian Medical Group.

Dr. Schwarze graduated from the AT Still University Kirksville College of Osteopathic Medicine (KCOM) in Kirksville, Missouri, in 1973. He completed his internship and residency in Internal Medicine at Normandy Osteopathic Hospital in St. Louis, Missouri.   He then attended the fellowship program in Cardiology at St. Louis University Hospital, where he continued to teach echocardiology part-time for 15 years. Upon completing his fellowship, Dr.Schwarze established a private practice, which existed for 32 years.   His group is now part of the BJC Medical Group in the Metropolitan St. Louis area. Dr. Schwarze is board certified in Internal Medicine and Cardiovascular Disease by the American Osteopathic Board of Internal Medicine.

Dr. Schwarze has researched echocardiology, congestive heart failure, and lipid therapy, which has resulted in several publications in these areas. He has spoken at numerous national programs and has been the program chairman of many educational symposia in cardiology. Dr. Schwarze has received four “Educator of the Year” awards and is a Master Fellow in the American College of Osteopathic Internists and a Fellow in the American College of Cardiology. He is also the past President of the St. Louis Chapter of the American Heart Association. He has received the Hugh McCollough Award and a Lifetime Achievement Award from the St. Louis Chapter of the AHA and a lifetime teaching award from Des Peres Hospital.

Dr. Schwarze discloses that he received speaker fees from BMS/Pfizer, Amgen, and Esperion.